Material/Methods: 7 women, who were highly suspected to develop local reccurency after BCT, were examined in our MRI department during 1.01.2003-30.01.2004. Mammography and ultrasond were not able to solve the problem in each of this casesResults: Based on breast MRI, the local reccurency ...
ASO Author Reflections: Breast Cancer Detection of Baseline Screening MRI in High-Risk Women Who Are Not in the Highest Risk GroupsAnnals of Surgical Oncology -doi:10.1245/s10434-020-08722-0Suzanne B. CoopeySpringer International PublishingAnnals of Surgical Oncology...
Prediction of pathological margin status using preoperative contrast‐enhanced MRI in patients with early breast cancer who underwent skin‐sparing mastectomyPrediction of pathological margin status using preoperative contrast‐enhanced MRI in patients with early breast cancer who underwent skin‐sparing mastecto...
Boschert, Sherry
Evaluation of Pathological Responses and Breast MRI Images in Breast Cancer Patients Who Have Received Neoadjuvant Therapy: A Single Center Experiencedoi:10.14744/cm.2023.29591Dastanl, SevinSnmez, SüleymanGündüz, NerminBulut, NilüferComprehensive Medicine...
Prognostic significance of a complete response on breast MRI in patients who received neoadjuvant chemotherapy according to the molecular subtype. Korean J Radiol 2015;16:986-995Ko ES, Han H, Han BK, et al. Prognostic significance of a com-plete response on breast MRI in patients who received...
p42 before mri what? treatment and follow-up of patients who underwent breast conservative surgery for breast cancer without preoperative mri evaluationdoi:10.1016/S0960-9776(07)70107-8S. VassilaroA. ApostolopoulouE. ZoisA. TsimbanisElsevier BVBreast...
The prediction of pathological margin using preoperative contrast-enhanced MRI for early breast cancer who performed skin-sparing mastectomy with immediate reconstructiondoi:10.1016/S0960-9776(17)30364-8A. KataokaM. SawakiM. HattoriJ. Ishiguro
The aim of this study was to combine breast MRI-derived biomarkers with clinical-pathological parameters to identify patients who truly need an Oncotype DX Breast Recurrence Score® (ODXRS) genomic assay, currently used to predict the benefit of adjuvant chemotherapy in ER-positive/HER2-negative ...
The PROSPECT trial rationale relies on the argument that if predicted lateral or distal margins are not threatened on MRI staging and an APER (which carries a high risk of a positive CRM) does not need to be performed (i.e., an upper or mid rectal cancer), then the risk of distant ...